Direct antimicrobial susceptibility testing of Gram-negative bacteria from positive blood cultures

Submitted: 18 March 2014
Accepted: 18 March 2014
Published: 18 March 2014
Abstract Views: 1741
PDF: 1228
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Every year, a great number of people die for bloodstream infections, especially by too late or inappropriate pharmacological treatment. The principal laboratory test for this type of infections is the blood culture; its limit is a turnaround time of about 96 hours. The aim of this work was to compare direct susceptibility testing with the automated VITEK 2 system. Fifty blood cultures, positive for Gram-negative bacteria, were processed for amikacin, ciprofloxacin, ceftazidime, piperacillin-tazobactam, cefotaxime, meropenem and colistin with VITEK 2 and direct susceptibility testing by Kirby-Bauer or E-test methods. We found 93.7% correlation with 5.0% minor errors, 0.5% very major errors and 0.8% major errors. Piperacillin-tazobactam has shown the lowest percentage of correlation (79%) and the highest percentage of errors (21%). To conclude, direct susceptibility testing of positive blood cultures has shown promising results, rendering this method useful for giving to clinicians preliminary informations for therapy.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Zappavigna, A., Cavatorta, E., Chiarabini, R., Schiavo, R., Padrini, D., Reboli, C., & Confalonieri, M. (2014). Direct antimicrobial susceptibility testing of Gram-negative bacteria from positive blood cultures. Microbiologia Medica, 28(3). https://doi.org/10.4081/mm.2013.3272